This document summarizes transition and problems with transition in rheumatology in Germany. It finds that there are several reasons for deficits in healthcare provision for young people, including a shortage of adult rheumatologists, a lack of transitional care programs, and a lack of government policies to support transition. Research has found that many young people feel their transition to adult healthcare was not well-prepared or planned. Efforts are underway to address these issues through the development of transition resources and guidelines to improve coordination and continuity of care for young people living with rheumatic diseases.
The document provides updates from Vietnam Medical News including:
1) The satellite hospital scheme has resulted in positive outcomes after 2 years, reducing overloading in major hospitals.
2) Vietnamese-made vaccines have met WHO standards for export.
3) Vietnam's Ministry of Health has proposed a right-to-die law, reopening debate around assisted suicide for terminal patients.
4) Various initiatives in Vietnam including fighting malaria in Ba Ria-Vung Tau province and honoring locally produced medicines.
This document discusses moving from current ad-hoc healthcare systems to a national learning health system. It outlines challenges facing healthcare like rising costs and an aging population. Current digital health data is underused. Examples show how data can enable epidemiological research, evaluate policies, and support clinical trials. Bigger efforts are needed to create a prototype national asthma learning health system. This would use various data sources to monitor asthma burden, improve outcomes and reduce deaths. The goal is an integrated system that continuously learns from patient care to drive discovery and improve value.
Healthcare Trends 2020: How the UK is Shaping the Medicine of the FutureAlex Artyomenko
The UK is shaping future medicine through initiatives that support healthcare innovation. An aging population and rising healthcare costs are driving technological advances like personalized medicine, home diagnostics, and digital health. The UK has committed over £1.8 billion to support over 7,600 organizations conducting projects in areas like cell and gene therapy, precision medicine, and drug discovery. These investments are estimated to add over £11.5 billion to the UK economy and create 55,000 new jobs. Emerging technologies will allow people to live longer, healthier lives with more customized treatment options.
1. O documento discute as definições e instrumentos de defesa comercial no Brasil, com foco em medidas antidumping, compensatórias e de salvaguarda.
2. Dumping é definido como exportar um produto a preço inferior ao valor normal no mercado doméstico, com três aspectos precisando ser caracterizados para aplicação de medidas antidumping: existência de dumping, dano à indústria doméstica e relação causal entre o dumping e o dano.
3. Subsídios são benefícios governamentais que direta ou indire
O documento discute o aumento do protecionismo comercial entre países devido à crise global desde 2008. O Brasil adotou um imposto interno diferente para veículos nacionais e importados, e espera-se que medidas adicionais de proteção ao mercado interno continuem pelos próximos anos para defender empregos locais. Embora medidas protecionistas possam ser desafiadas na OMC, especialistas acreditam que a medida brasileira é defensável dadas as circunstâncias econômicas atuais.
1) O documento discute barreiras comerciais, definindo-as como restrições impostas ao comércio exterior por governos. 2) Apresenta barreiras tarifárias como taxas e impostos sobre importações, e barreiras não-tarifárias como quotas, licenças e requisitos técnicos que dificultam importações. 3) Fornece vários exemplos de barreiras tarifárias e não-tarifárias.
Aula 52 barreiras ao comércio internacionalpetecoslides
O documento discute as barreiras ao comércio internacional, incluindo barreiras naturais como moeda e idioma, e barreiras protecionistas como subsídios, tarifas alfandegárias e cotas de importação/exportação. Também menciona formas de entrave como dumping, oligopólios, trusts e cartéis, além de novas barreiras como técnicas, ecológicas e burocráticas. A conclusão indica que embora a OMC tenha reduzido barreiras, disputas comerciais entre países cri
The document provides updates from Vietnam Medical News including:
1) The satellite hospital scheme has resulted in positive outcomes after 2 years, reducing overloading in major hospitals.
2) Vietnamese-made vaccines have met WHO standards for export.
3) Vietnam's Ministry of Health has proposed a right-to-die law, reopening debate around assisted suicide for terminal patients.
4) Various initiatives in Vietnam including fighting malaria in Ba Ria-Vung Tau province and honoring locally produced medicines.
This document discusses moving from current ad-hoc healthcare systems to a national learning health system. It outlines challenges facing healthcare like rising costs and an aging population. Current digital health data is underused. Examples show how data can enable epidemiological research, evaluate policies, and support clinical trials. Bigger efforts are needed to create a prototype national asthma learning health system. This would use various data sources to monitor asthma burden, improve outcomes and reduce deaths. The goal is an integrated system that continuously learns from patient care to drive discovery and improve value.
Healthcare Trends 2020: How the UK is Shaping the Medicine of the FutureAlex Artyomenko
The UK is shaping future medicine through initiatives that support healthcare innovation. An aging population and rising healthcare costs are driving technological advances like personalized medicine, home diagnostics, and digital health. The UK has committed over £1.8 billion to support over 7,600 organizations conducting projects in areas like cell and gene therapy, precision medicine, and drug discovery. These investments are estimated to add over £11.5 billion to the UK economy and create 55,000 new jobs. Emerging technologies will allow people to live longer, healthier lives with more customized treatment options.
1. O documento discute as definições e instrumentos de defesa comercial no Brasil, com foco em medidas antidumping, compensatórias e de salvaguarda.
2. Dumping é definido como exportar um produto a preço inferior ao valor normal no mercado doméstico, com três aspectos precisando ser caracterizados para aplicação de medidas antidumping: existência de dumping, dano à indústria doméstica e relação causal entre o dumping e o dano.
3. Subsídios são benefícios governamentais que direta ou indire
O documento discute o aumento do protecionismo comercial entre países devido à crise global desde 2008. O Brasil adotou um imposto interno diferente para veículos nacionais e importados, e espera-se que medidas adicionais de proteção ao mercado interno continuem pelos próximos anos para defender empregos locais. Embora medidas protecionistas possam ser desafiadas na OMC, especialistas acreditam que a medida brasileira é defensável dadas as circunstâncias econômicas atuais.
1) O documento discute barreiras comerciais, definindo-as como restrições impostas ao comércio exterior por governos. 2) Apresenta barreiras tarifárias como taxas e impostos sobre importações, e barreiras não-tarifárias como quotas, licenças e requisitos técnicos que dificultam importações. 3) Fornece vários exemplos de barreiras tarifárias e não-tarifárias.
Aula 52 barreiras ao comércio internacionalpetecoslides
O documento discute as barreiras ao comércio internacional, incluindo barreiras naturais como moeda e idioma, e barreiras protecionistas como subsídios, tarifas alfandegárias e cotas de importação/exportação. Também menciona formas de entrave como dumping, oligopólios, trusts e cartéis, além de novas barreiras como técnicas, ecológicas e burocráticas. A conclusão indica que embora a OMC tenha reduzido barreiras, disputas comerciais entre países cri
Using information to deliver world-class care at lower cost. CernerFundació TicSalut
III Edició "The British Experience in Technologies for Health". Hospital de Sant Pau, Barcelona. 9 de novembre de 2011. Esdeveniment organitzat per la Fundació TICSalut i el Departament de Comerç i Inversions del Consolat General Britànic a Barcelona, UK Trade & Investment, per posar en contacte oportunitats i coneixements entre el Regne Unit i Catalunya.
- Influenza vaccination rates among healthcare workers and high-risk groups in London are well below national targets and averages, putting patients and others at risk. Vaccination rates for nurses in London were only 32.3% in the 2012-2013 season.
- Low vaccination rates undermine "herd immunity" efforts to protect vulnerable groups who cannot be vaccinated. Healthcare workers are an important vector for transmitting flu since they can be infected but asymptomatic.
- The document calls on respiratory clinicians to lead by getting vaccinated themselves, encouraging vaccination among colleagues and patients, and collecting data to share on vaccination efforts. Various resources are provided to support increasing uptake.
- The document discusses building a digital health ecosystem in Africa using mobile technology to transform healthcare delivery. It describes how patient monitoring solutions using digital devices can generate savings for hospitals by reducing readmissions for chronic diseases.
- The medopad platform is presented as an integrated digital health solution that can enable real-time patient monitoring, care coordination between patients and providers, and clinical research across different diseases like cardiology, oncology and diabetes.
- Examples of pilot programs using medopad in cancer and cardiology care demonstrate improved outcomes and cost savings. The platform aims to connect the global healthcare community to enhance care in developing countries.
This document provides an overview of several articles in an issue of the magazine gesundhyte.de, which focuses on digital health and systems medicine. It includes introductions and summaries of articles that discuss using research data to improve healthcare, challenges in data standardization, and personal experiences of researchers during the COVID-19 pandemic. Interviews are also highlighted with scientists working in fields like outbreak detection and data integration. The introductions emphasize how data-driven research can help address current and future medical issues.
Childhood Tuberculosis and Community Healthcare_Kechi Achebe_5.8.14CORE Group
- Childhood tuberculosis (TB) is a significant but underrecognized public health problem, with around 500,000 children developing TB annually and 64,000 dying from it. Actual cases are likely higher than reported.
- Children face barriers to accurate TB diagnosis including non-specific symptoms, difficulty obtaining sputum samples, and lack of screening guidelines. Contact tracing of children exposed to TB patients is also lacking.
- Integrating childhood TB screening and management into existing community health platforms could help improve case detection and ensure children complete treatment.
Telehealth in Urology: A Systematic Review of the Literature.Valentina Corona
This systematic review identified 45 studies evaluating telehealth applications in urology. The studies covered prostate cancer (11 studies), hematuria management (3 studies), urinary stones (6 studies), urinary incontinence (14 studies), urinary tract infections (5 studies), and other conditions (6 studies). The available evidence indicates that telehealth has been successfully used for decision-making in prostate cancer, follow-up care of prostate cancer and urinary incontinence patients, initial diagnosis of hematuria and urinary tract infections, and management of uncomplicated urinary stones. However, more robust data on long-term outcomes, safety, and cost-effectiveness are still needed. The COVID-19 pandemic is likely
This document summarizes a presentation given by Anastasia Pharris of the European Centre for Disease Prevention and Control on infections among people who inject drugs. It finds that over 30,000 new HIV diagnoses in Europe in 2016 were due to injecting drug use, with most cases concentrated in Eastern Europe. While harm reduction efforts have made progress in some countries, people who inject drugs still face high burdens of HIV, hepatitis C, and other infections. The presentation calls for improved testing, treatment, and prevention programs targeting this group.
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...ILC- UK
COVID-19 has had devastating effects on health systems and economies across the world and has put the importance of the prevention of ill health throughout the life course into sharp focus– from the importance of better pandemic preparedness to the need to promote the overall health of the population.
This ILC webinar is part of our “Delivering prevention in an ageing world” programme.
The panellists presented their country perspectives on how each of their countries have responded to COVID-19 and what we can learn from the pandemic for the prevention agenda going forward.
The document summarizes WHO Regional Office for Europe’s programs and actions for public health. It discusses increasing life expectancy in the region from 75 to 82 years on average but notes inequities persist. It also outlines priority areas for action like investing in health promotion, tackling noncommunicable diseases, and strengthening health systems and emergency preparedness. Specific country programs are highlighted in areas like reducing tobacco use, eliminating measles and rubella, and improving migrant health.
Ten Years of Success Stories in Telemedicine - Med-e-Tel Luxembourg (April 2012)Ofer Atzmon
Telemedicine has seen consistent growth over the past 15 years and is shifting from hospitals to homes and mobile devices. Chronic disease management and remote monitoring of conditions like cardiovascular disease are major areas of growth due to aging populations and rising healthcare costs. Success stories demonstrate benefits like reduced hospitalizations and costs through remote monitoring of patients with conditions like heart disease and COPD. Further growth depends on addressing challenges and stakeholders cooperating to plan and manage programs.
Professor Benedetta Allegranzi,World Health Organisation
Dr. Benedetta Allegranzi is a specialist in infectious diseases, tropical medicine, infection prevention and control and hospital epidemiology. She currently works at the World Health Organization HQ (Service Delivery and Safety department), leading the "Clean Care is Safer Care" programme. Since 2013, Dr Allegranzi has gathered the title of professor of infectious diseases in the official Italian professorship list and is adjunct professor attached to the Institute of Global Health at the Faculty of Medicine, University of Geneva, Switzerland. She closely collaborates with the team at the IPC and WHO Collaborating Center on Patient Safety, University of Geneva Hospitals (Geneva, Switzerland), as well as with the Armstrong Institute for Patient Safety and Quality, John Hopkins University, (Baltimore, USA) for clinical research projects. She is currently involved in the leadership on the WHO Ebola Response in the field of IPC and supervises IPC activities in Sierra Leone and Guinea. She has experience in clinical management of infectious diseases and tropical medicine, and clinical research in healthcare settings in both developing and developed countries. She has thorough skills and experience in training and education.
She is also the author or coauthor of more than 150 scientific publications, including articles published in high-profile medical journal such as the Lancet, Lancet Infectious Diseases, New England Journal of Medicine and the WHO Bulletin, and six book chapters.
A presentation on my life in public health and vaccinations- from measles in the West Midlands of England, 1983-2014 to COVID-19 in Europe, 2020-now, implications for the public health community and vaccines manufactures including the vaccine TRIPS waiver. Presentation to a Spanish public health and vaccines forum, October 18th 2021 211018 middleton spanish vaccines and industry presentation 1 version recorded
Lucia PASTORE CELENTANO, MD, MSc
Head of the Vaccine Preventable Diseases Programme, ECDC
“Addressing vaccine hesitancy in challenging times”
European Health Forum Gastein, 05 October 2017
The meaning of meningococcal carriage - Slideset by Professor Adam FinnWAidid
Professor Finn on the risks of meningococcal
disease. The slideset face the effects of vaccines, the speculation about meningococcal infection and respiratory viruses, so as the epidemiology & evolving vaccine
strategies in Europe and Africa.
Policy briefing launch: Ready to rollout – Improving uptake of routine immuni...ILC- UK
The document discusses recommendations for improving routine immunization uptake in the UK post-pandemic, including raising awareness of vaccine benefits, using personal health data effectively, and enabling collaboration on immunization at national and local levels. It provides an example of co-producing maternity immunization messaging with service users at Homerton University Hospital to improve uptake by framing information around benefits rather than risks. The recommendations also involve working with integrated care systems and taking a Make Every Contact Count approach.
Presentation from the opening session of the 17th European AIDS Conference (EACS) 2019, Basel, Switzerland.
Presenter: Anastasia Pharris, European Centre for Disease Prevention and Control.
The document discusses the activities of EULAR PARE (European League Against Rheumatism Patient Research Partner). It outlines PARE's objectives of raising awareness of rheumatic and musculoskeletal diseases, supporting patient organizations, educating patient representatives, and enhancing patient involvement. It describes two of PARE's main programs - the Knowledge Transfer Programme, which funds collaboration projects between organizations, and the Engagement Programme, which aims to improve quality of life for people with rheumatic diseases through national organizations. It provides examples of other activities including an annual conference, writing competition, newsletter, and involvement in research initiatives.
Using information to deliver world-class care at lower cost. CernerFundació TicSalut
III Edició "The British Experience in Technologies for Health". Hospital de Sant Pau, Barcelona. 9 de novembre de 2011. Esdeveniment organitzat per la Fundació TICSalut i el Departament de Comerç i Inversions del Consolat General Britànic a Barcelona, UK Trade & Investment, per posar en contacte oportunitats i coneixements entre el Regne Unit i Catalunya.
- Influenza vaccination rates among healthcare workers and high-risk groups in London are well below national targets and averages, putting patients and others at risk. Vaccination rates for nurses in London were only 32.3% in the 2012-2013 season.
- Low vaccination rates undermine "herd immunity" efforts to protect vulnerable groups who cannot be vaccinated. Healthcare workers are an important vector for transmitting flu since they can be infected but asymptomatic.
- The document calls on respiratory clinicians to lead by getting vaccinated themselves, encouraging vaccination among colleagues and patients, and collecting data to share on vaccination efforts. Various resources are provided to support increasing uptake.
- The document discusses building a digital health ecosystem in Africa using mobile technology to transform healthcare delivery. It describes how patient monitoring solutions using digital devices can generate savings for hospitals by reducing readmissions for chronic diseases.
- The medopad platform is presented as an integrated digital health solution that can enable real-time patient monitoring, care coordination between patients and providers, and clinical research across different diseases like cardiology, oncology and diabetes.
- Examples of pilot programs using medopad in cancer and cardiology care demonstrate improved outcomes and cost savings. The platform aims to connect the global healthcare community to enhance care in developing countries.
This document provides an overview of several articles in an issue of the magazine gesundhyte.de, which focuses on digital health and systems medicine. It includes introductions and summaries of articles that discuss using research data to improve healthcare, challenges in data standardization, and personal experiences of researchers during the COVID-19 pandemic. Interviews are also highlighted with scientists working in fields like outbreak detection and data integration. The introductions emphasize how data-driven research can help address current and future medical issues.
Childhood Tuberculosis and Community Healthcare_Kechi Achebe_5.8.14CORE Group
- Childhood tuberculosis (TB) is a significant but underrecognized public health problem, with around 500,000 children developing TB annually and 64,000 dying from it. Actual cases are likely higher than reported.
- Children face barriers to accurate TB diagnosis including non-specific symptoms, difficulty obtaining sputum samples, and lack of screening guidelines. Contact tracing of children exposed to TB patients is also lacking.
- Integrating childhood TB screening and management into existing community health platforms could help improve case detection and ensure children complete treatment.
Telehealth in Urology: A Systematic Review of the Literature.Valentina Corona
This systematic review identified 45 studies evaluating telehealth applications in urology. The studies covered prostate cancer (11 studies), hematuria management (3 studies), urinary stones (6 studies), urinary incontinence (14 studies), urinary tract infections (5 studies), and other conditions (6 studies). The available evidence indicates that telehealth has been successfully used for decision-making in prostate cancer, follow-up care of prostate cancer and urinary incontinence patients, initial diagnosis of hematuria and urinary tract infections, and management of uncomplicated urinary stones. However, more robust data on long-term outcomes, safety, and cost-effectiveness are still needed. The COVID-19 pandemic is likely
This document summarizes a presentation given by Anastasia Pharris of the European Centre for Disease Prevention and Control on infections among people who inject drugs. It finds that over 30,000 new HIV diagnoses in Europe in 2016 were due to injecting drug use, with most cases concentrated in Eastern Europe. While harm reduction efforts have made progress in some countries, people who inject drugs still face high burdens of HIV, hepatitis C, and other infections. The presentation calls for improved testing, treatment, and prevention programs targeting this group.
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...ILC- UK
COVID-19 has had devastating effects on health systems and economies across the world and has put the importance of the prevention of ill health throughout the life course into sharp focus– from the importance of better pandemic preparedness to the need to promote the overall health of the population.
This ILC webinar is part of our “Delivering prevention in an ageing world” programme.
The panellists presented their country perspectives on how each of their countries have responded to COVID-19 and what we can learn from the pandemic for the prevention agenda going forward.
The document summarizes WHO Regional Office for Europe’s programs and actions for public health. It discusses increasing life expectancy in the region from 75 to 82 years on average but notes inequities persist. It also outlines priority areas for action like investing in health promotion, tackling noncommunicable diseases, and strengthening health systems and emergency preparedness. Specific country programs are highlighted in areas like reducing tobacco use, eliminating measles and rubella, and improving migrant health.
Ten Years of Success Stories in Telemedicine - Med-e-Tel Luxembourg (April 2012)Ofer Atzmon
Telemedicine has seen consistent growth over the past 15 years and is shifting from hospitals to homes and mobile devices. Chronic disease management and remote monitoring of conditions like cardiovascular disease are major areas of growth due to aging populations and rising healthcare costs. Success stories demonstrate benefits like reduced hospitalizations and costs through remote monitoring of patients with conditions like heart disease and COPD. Further growth depends on addressing challenges and stakeholders cooperating to plan and manage programs.
Professor Benedetta Allegranzi,World Health Organisation
Dr. Benedetta Allegranzi is a specialist in infectious diseases, tropical medicine, infection prevention and control and hospital epidemiology. She currently works at the World Health Organization HQ (Service Delivery and Safety department), leading the "Clean Care is Safer Care" programme. Since 2013, Dr Allegranzi has gathered the title of professor of infectious diseases in the official Italian professorship list and is adjunct professor attached to the Institute of Global Health at the Faculty of Medicine, University of Geneva, Switzerland. She closely collaborates with the team at the IPC and WHO Collaborating Center on Patient Safety, University of Geneva Hospitals (Geneva, Switzerland), as well as with the Armstrong Institute for Patient Safety and Quality, John Hopkins University, (Baltimore, USA) for clinical research projects. She is currently involved in the leadership on the WHO Ebola Response in the field of IPC and supervises IPC activities in Sierra Leone and Guinea. She has experience in clinical management of infectious diseases and tropical medicine, and clinical research in healthcare settings in both developing and developed countries. She has thorough skills and experience in training and education.
She is also the author or coauthor of more than 150 scientific publications, including articles published in high-profile medical journal such as the Lancet, Lancet Infectious Diseases, New England Journal of Medicine and the WHO Bulletin, and six book chapters.
A presentation on my life in public health and vaccinations- from measles in the West Midlands of England, 1983-2014 to COVID-19 in Europe, 2020-now, implications for the public health community and vaccines manufactures including the vaccine TRIPS waiver. Presentation to a Spanish public health and vaccines forum, October 18th 2021 211018 middleton spanish vaccines and industry presentation 1 version recorded
Lucia PASTORE CELENTANO, MD, MSc
Head of the Vaccine Preventable Diseases Programme, ECDC
“Addressing vaccine hesitancy in challenging times”
European Health Forum Gastein, 05 October 2017
The meaning of meningococcal carriage - Slideset by Professor Adam FinnWAidid
Professor Finn on the risks of meningococcal
disease. The slideset face the effects of vaccines, the speculation about meningococcal infection and respiratory viruses, so as the epidemiology & evolving vaccine
strategies in Europe and Africa.
Policy briefing launch: Ready to rollout – Improving uptake of routine immuni...ILC- UK
The document discusses recommendations for improving routine immunization uptake in the UK post-pandemic, including raising awareness of vaccine benefits, using personal health data effectively, and enabling collaboration on immunization at national and local levels. It provides an example of co-producing maternity immunization messaging with service users at Homerton University Hospital to improve uptake by framing information around benefits rather than risks. The recommendations also involve working with integrated care systems and taking a Make Every Contact Count approach.
Presentation from the opening session of the 17th European AIDS Conference (EACS) 2019, Basel, Switzerland.
Presenter: Anastasia Pharris, European Centre for Disease Prevention and Control.
Similar to ENCA 2016 - Genoa - Kirsten Minden (20)
The document discusses the activities of EULAR PARE (European League Against Rheumatism Patient Research Partner). It outlines PARE's objectives of raising awareness of rheumatic and musculoskeletal diseases, supporting patient organizations, educating patient representatives, and enhancing patient involvement. It describes two of PARE's main programs - the Knowledge Transfer Programme, which funds collaboration projects between organizations, and the Engagement Programme, which aims to improve quality of life for people with rheumatic diseases through national organizations. It provides examples of other activities including an annual conference, writing competition, newsletter, and involvement in research initiatives.
KOURIR is a French non-profit association established in 1992 to support parents and children with juvenile idiopathic arthritis (JIA) and other pediatric rheumatic diseases. It has around 400 members, mainly parents, and raises funds through membership fees and events to support families, increase awareness of JIA, and promote research. The association provides information and resources to families and medical professionals, participates in advocacy events, and offers services like a helpline, conferences, and outings for children affected by JIA.
This document summarizes the experiences of patients transitioning from pediatric to adult rheumatology care in the Netherlands. Most university hospitals in the Netherlands facilitate a transition process where patients have one or more joint appointments with both their pediatric and new adult rheumatologist starting around ages 16-18. These transitions are meant to increase patient confidence by allowing them to meet the new adult doctor before fully transitioning. The document describes the author's own positive transition experience and quotes from other patients, some of whom felt they needed more than one joint appointment to feel fully prepared. It outlines some of the key differences between pediatric and adult clinics that the transition helps patients adjust to.
The Children's Chronic Arthritis Association (CCAA) provides support for children with Juvenile Idiopathic Arthritis (JIA) and their families. It was founded in 1985 and offers educational and recreational opportunities through family support weekends and small grants. The annual family support weekends, held in the New Forest and Peak District, allow children to meet others with JIA and participate in fun activities while families access information sessions. The CCAA relies on donations to fund these support services and programs.
This document summarizes the treatment protocols and transition experience for patients with juvenile idiopathic arthritis (JIA) in Slovenia. It discusses the treat-to-target approach for JIA, which aims for clinical remission. Treatment involves pharmacological interventions, physical therapy, and psychosocial support from a multidisciplinary team with a focus on patient-centered care. The document outlines treatment indications, protocols, and efficacy for medications like methotrexate and biologics. It also describes Slovenia's transition program which aims to transfer pediatric JIA patients to adult care starting in early adolescence through a structured multi-year process.
The SHARE project aimed to improve care and research collaborations for pediatric rheumatology in Europe from 2012-2015. Key results included:
1. Surveys identifying needs in European countries and best practices for diagnosis, treatment, and obtaining consent.
2. Development of consensus treatment guidelines for conditions like JDM and childhood SLE through literature reviews and expert consensus.
3. An updated pediatric rheumatology website and patient information translated into multiple languages.
4. Papers identifying barriers to international data and sample sharing between countries due to differences in ethical approval processes.
The project provided guidance to improve uniformity of care for pediatric rheumatic diseases across Europe and opportunities to facilitate research collaboration and influence European policies.
ENCA is a non-profit organization that works to support associations for juvenile idiopathic arthritis (JIA) across Europe. ENCA gathers information from medical associations and doctors, shares it with associations worldwide, and disseminates medical knowledge to parents and healthcare systems. ENCA also helps fund research projects and works closely with PRES and PRINTO on conferences and studies. Through collaboration, ENCA has increased knowledge of JIA and created a network for organizations and families to access expertise.
1) The parents cooperation network in Hungary aims to promote early recognition of juvenile idiopathic arthritis (JIA) and ensure timely medical support and advice for affected children and families.
2) A JIA Parents Club has been established with the support of Dr. Ilonka Orban to share information via a Facebook page that now has over 1,500 likes and comments.
3) A Family Day event was organized in Budapest in September 2016 with Dr. Orban available for consultations, though participation was lower than expected. Future plans include more open days, events, and transforming the club into a foundation to support treatment access.
This document discusses the development of a video game called AJIKO aimed at children suffering from Juvenile Idiopathic Arthritis (JIA). It was created using an ADDIE pedagogical model of analysis, design, development, implementation, and evaluation. A steering committee decided on the game format, themes, and pedagogical messages to convey about the hospital process, treatments, exams, and rehabilitation through skill games and quizzes. The game was developed using the Unity engine to be accessible on computers, smartphones and tablets. It takes place in a hospital setting and features two child avatars to help players identify with the characters. AJIKO is the first serious game dedicated to JIA and
A focus group was held in October 2015 with 5 young people sharing their experiences with invisible illnesses in schools, such as being treated as "the ill kid", not being allowed to use disabled facilities, and teachers not making an effort to understand their rare conditions or communicate limitations to other staff. An information workshop was then held in April 2016 to develop informational packs on invisible illnesses for schools, which would include tips, games, accessible toilet signs, health passports, communication strategies, and fundraising ideas. Next steps are to review content, pursue financing, produce and distribute the packs, complete a website, and promote inclusive education.
The document outlines age ranges from 0-18+ years old and mentions an "Information day AC team". It seems to be providing information about different age groups and an event related to an athletic club.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
1. Kirsten Minden
German Rheumatism Research Centre
University Medicine Charité Berlin
ENCA-Meeting Genoa: September 30th 2016
Transition and problems
in transition in Germany
2. Germany - Facts
Member of the EU since 1958
Federal government led by
Christian and Social Democrats
under Chancellor Angela Merkel
Compulsory
health insurance
Health care is financed
from the premiums
paid by insured employees
and employers, and
from tax revenue surpluses
3. Source: Health at a Glance: Europe 2014, OECD
Health expenditure per capita
Germany - Facts
4. N = 80.6 MioPyramid in 2016
men (in thousand) women (in thousand)
Age in years
Juvenile arthritis, CTD/vas-
culitis, autoinflammatory
disease → ≈17,000
Rheumatoid arthritis 500,000
Spondyloarthritis 630,000
CTD/vasculitis 70,000
Others 210,000
→ ≈1.5 million
… in adulthood
… in childhood/adolescence
13 million up
to the age of 18
Germany - Facts
Population
6. now20001990
Transition in rheumatology in Germany
Assessment of the health care situation of
young people with JA during transition
2010 2030
ENCA meeting, Genoa
7. now20001990
Transition in rheumatology in Germany
2010 2030
Plenary session on transition for adult rheumatologists
at the national rheumatology congress in 2005
ENCA meeting, Genoa
Assessment of the health care situation of
young people with JA during transition
8. now20001990
Transition research in rheumatology in Germany
2010 2030
3-year-follow-up-study of 250 patients
leaving paediatric rheumatologic care
Assessing the health status of severely affec-
ted JIA patients from the biologic
registry BiKeR during transition
Assessment of health service
utilisation by young people
using a large claims dataset
Assessment of the health care situation of
young people with JA during transition
Plenary session on transition for adult rheumatologists
at the national rheumatology congress in 2005
Inside the
specialised
care setting
On popu-
lation level
9. 37%63%
in adult
specialty care
without adult
rheumatologic care
three years after the patients had left paediatric rheuma-
tologic care
Proportion of patients (%)
Health care utilisation of young people with JIA
Data source: project focus transition
10. now20001990
Transition research in rheumatology in Germany
2010 2030
3-year-follow-up-study of 250 patients
leaving paediatric rheumatologic care
Assessing the health status of severely affec-
ted JIA patients included in the
biologic registry during transition
Assessment of health service
utilisation by young people
using a large claims dataset
Assessment of the health care situation of
young people with JA during transition
Plenary session on transition for adult rheumatologists
at the national rheumatology congress in 2005
Inside the
specialised
care setting
On popu-
lation level
11. Health care utilisation of young people with JIA
Data source: claims data from 2008 to 2014
Age in years
16
20
18
Continuous
follow-up
Patients with JIA
(N=256)
Patients in adult
specialty care 31%
12. Health care utilisation of young people with JIA
Data source: claims data from 2008 to 2014
Age in years
16
20
18
Continuous
follow-up
Patients on
DMARDs (N=103)
Patients with JIA
(N=256)
Patients in adult
specialty care 31%
DMARDs = Disease Modi-
fying Antirheumatic Drugs
(e.g., methotrexate, biologics)
13. Health care utilisation of young people with JIA
Data source: claims data from 2008 to 2014
Age in years
16
20
18
Continuous
follow-up
Patients in adult
specialty care 51%
Patients in GP
care alone 31%
Patients on
DMARDs (N=103)
Patients with JIA
(N=256)
Patients in adult
specialty care 31%
14. Health care utilisation of young people with JIA
Data source: claims data from 2008 to 2014
Age in years
16
20
18
Continuous
follow-up
Patients in adult
specialty care 51%
Patients in GP
care alone 31%
Patients on
DMARDs (N=103)
Patients with JIA
(N=256)
Patients in adult
specialty care 31%
DMARDs in 79% DMARDs in 22%
15. Reasons for deficits in YP´s health care provision
Lack of government supported transition policies or strategies
16. Health system strategies supporting transition
No policies or strategies
No policies or strategies
No policies or strategies
No policies or strategies
2008 Transition sup-
port programme
2008-11 funding to deve-
lop transition
initiatives in 11
regions
Documents outlining the
need
„Better Outcomes Better
Futures: The National Po-
licy Framework for Chil-
dren and Young People
2014-2020“
Hepburn et al. Arch Dis Child 2015;100:559.
17. Reasons for deficits in YP´s health care provision
Shortage of adult rheumatologists
Lack of government supported transition policies or strategies
18. Man power in rheumatology in Germany
Target
number
Actual
number
Adult rheuma-
tologists
1,350
(2:100,000)
750
Number of specialists needed for outpatient care
Memorandum DGRh 2008; Federal Medical Association 2015;
BVOU 2016.
19. Man power in rheumatology in Germany
Target
number
Actual
number
Adult rheuma-
tologists
1,350
(2:100,000)
750
Paediatric
rheumatologists
125
(1:100,000)
164
Number of specialists needed for outpatient care
1.3 / 100,000
International comparison
Paediatric rheumatologists/100,000 children Canada 0.83 at 15 sites
USA 0.53 at 42 sites
NL 0.47 at 7 sites
20. Man power in rheumatology in Germany
Actual
number
Paediatric
rheumatologists
164
Number of specialists
n = 31
n = 31
Other children hospitals
University hospitals
Self-employed paediatri-
cians
n = 30
21. 0% 20% 40% 60% 80% 100%
strongly agree somewhat agree strongly disagree
Survey among 250 young people with rheumatic diseases two years
after leaving paediatric specialty care
well prepared
well planned
at the right time
generally satisfactory
Reality of transitional care in Germany
The transfer to adult care was ...
Data source: project focus transition
22. 0% 20% 40% 60% 80% 100%
strongly agree somewhat agree strongly disagree
Survey among 250 young people with rheumatic diseases two years
after leaving paediatric specialty care
well prepared
well planned
at the right time
generally satisfactory
Reality of transitional care in Germany
The transfer to adult care was ...
Data source: project focus transition
23. 0% 20% 40% 60% 80% 100%
strongly agree somewhat agree strongly disagree
Survey among 250 young people with rheumatic diseases two years
after leaving paediatric specialty care
well prepared
well planned
at the right time
generally satisfactory
Reality of transitional care in Germany
The transfer to adult care was ...
Data source: project focus transition
24. 0% 20% 40% 60% 80% 100%
strongly agree somewhat agree strongly disagree
Survey among 250 young people with rheumatic diseases two years
after leaving paediatric specialty care
well prepared
well planned
at the right time
generally satisfactory
Reality of transitional care in Germany
The transfer to adult care was ...
Data source: project focus transition
25. 31%
20% 33%47%
Before
transfer
Before and up to
two years after
transfer
Unknown
Direct communication between
paediatric and adult rheumatologist
Reality of transitional care in Germany
Data source: project focus transition
26. Reasons for deficits in YP´s health care provision
Shortage of adult rheumatologists
Lack of transitional care programmes at rheumatologic centres
Lack of government supported transition policies or strategies
27. 9
9
31
10
no special service
no transition policy, but
interest in developing one
standard, informal procedure in transitioning
patients, but no written transition policy
written transition policy
Survey among 100 peadiatric rheumatology centres, where
members of the Society of Paediatric Rheumatogy are working
Reality of transitional care in Germany
Data source: GKJR Survey 2016
28. Legend: Quality indicators for paediatric rheumatology sites
Certified training facility for paediatric rheumatology
More than 200 children and adolescents with an
inflammatory rheumatic disease are treated at this site
Multiprofessional team available
Inpatient care available
Joint transition clinic and/or written transition policy
Map showing paediatric rheumatology care services
Website of the Society of Paediatric Rheumatology
29. Date source: GKJR-Survey 2016
Specific icon
joint transition clinics
and/or a written
transition policy
(N=28)
Map on http://www.gkjr.de/
Paediatric rheumatologic sites with …
30. Published transitional care programmes in Europe
United Kingdom
Growing up and moving on
MAGICC
Ready Steady Go
Germany
Berlin Transition Programme
Belgium
DON´T RETARD
Netherlands
Transition clinic
On your own feet ahead
Clemente et al.
Semin Arthritis Rheum. 2016 Jun 9.
31. Generic programme developed at the
DRK hospital Berlin
Financed by statutory health insurances
(e.g., TKK, AOK Nordost und BKK VBU)
Open for young people aged 16-20 years
with rheumatic diseases from 8 Federal
states
Berlin transition programme
Müther. http://www.drk-kliniken-berlin.de
32. Key elements
Central case management
Information flyer for physicians, teens/
parents
2 transition clinics before and 1
transition clinic after transfer
Questionnaire for teens/parents
T-booklet
Berlin transition programme
Müther. http://www.drk-kliniken-berlin.de
25 patients with JIA included since 2013,
no data on its effectiveness are available.
33. Reasons for deficits in YP´s health care provision
Shortage of adult rheumatologists
Lack of transitional care programmes at rheumatologic centres
Lack of financial incentives and institutional support for transition
services
Lack of government supported transition policies or strategies
34. Reasons for deficits in YP´s health care provision
Shortage of adult rheumatologists
Lack of transitional care programmes at rheumatologic centres
Lack of awareness of the necessity of ongoing care by the YP
Lack of financial incentives and institutional support for transition
services
Lack of government supported transition policies or strategies
36. Reasons for deficits in YP´s health care provision
Shortage of adult rheumatologists
Lack of transitional care programmes at rheumatologic centres
Dissatisfaction by the YP with adult health care
Lack of awareness of the necessity of ongoing care by the YP
Lack of financial incentives and institutional support for transition
services
Lack of government supported transition policies or strategies
37. 44%
79%
80%
68%
74%
32%
50%
53%
41%
44%
33%
53%
67%
51%
56%
getting an appointment,
if urgently needed
the time that the doctor
has for me
the knowlegde of the doctor
about my illness
taking me seriously
answering questions
Paediatric rheumato-
logy, at transfer
Adult rheumatology,
1 year after transfer
Adult rheumatology,
2 years after transfer
Satisfaction with specialised care by young people
in terms of …
Data source: project focus transition
38. Reasons for deficits in YP´s health care provision
Shortage of adult rheumatologists
Lack of transitional care programmes at rheumatologic centres
Dissatisfaction by the YP with adult health care
Lack of awareness of the necessity of ongoing care by the YP
Lack of financial incentives and institutional support for transition
services
Lack of resources, unmet education and training needs by health
professionals
Lack of government supported transition policies or strategies
39. 20001990
Transition in rheumatology in Germany
2010 2030
5 Paediatric rheumatologists
7 Adult rheumatologists
1 Psychologist
1 Health scientist
2 Patient representatives
Scientific societies for paediatric and
adult rheumatology
Working group on transition
2014
Several studies on transitional care
→ Deficits in health care services
40. Training course:
„Paediatric rheumatology meets
adult rheumatology“
Topics
Juvenile rheumatic diseases
Adolescence/young adulthood
Social support measures
...
First course at the annual rheuma-
tology meeting in September 2016
Transition resources for rheumatology
= national rheumatology
training academy
44. Transition resources for rheumatology
Transition-Peers 10 young women with rheumatic diseases,
aged 20-32 years
Specifically trained by the Rheuma-Liga
(physicians, psychologists, social worker)
45. Transition resources for rheumatology
Transition-Peers
Tell their own stories
Inform about transition
Promote autonomy and self-
management of disease
Provide contacts, tips
Answer to questions
50. Feed-back form for paediatric
rheumatologist
Transition resources for rheumatology
Confirming
transfer into adult practice
receipt of referral letter, imaging,
etc.
51. 2015
1) Transition-camp at Bodensee
once a year in spring
since 2010
2) Transition-camp organised by
the Rheuma-Liga, in autumn
Helmstedt 07./08.10.2016
2010
Transition resources for rheumatology
52. 20001990
Transition in rheumatology in Germany
Several studies on transitional care
→ Deficits in health care services
2010 2030
Working group
on transition
now
Various resources for patients
and health care providers
available,
more in development
Most health spending is publicly financed in nearly all EU countries.
On average, almost three-quarter was publicly financed in 2012
A total of 59% of 16-year-old JIA patients were treated by rheumatologists, of whom 49% were paediatric and 14% were adult health care providers. The proportion of patients in specialised care decreased continuously within the observed 4-year period to 37% in 20-year-old patients
Alle: 45% zu 30% DMARDs
A total of 59% of 16-year-old JIA patients were treated by rheumatologists, of whom 49% were paediatric and 14% were adult health care providers. The proportion of patients in specialised care decreased continuously within the observed 4-year period to 37% in 20-year-old patients
Alle: 45% zu 30% DMARDs
A total of 59% of 16-year-old JIA patients were treated by rheumatologists, of whom 49% were paediatric and 14% were adult health care providers. The proportion of patients in specialised care decreased continuously within the observed 4-year period to 37% in 20-year-old patients
Alle: 45% zu 30% DMARDs
A total of 59% of 16-year-old JIA patients were treated by rheumatologists, of whom 49% were paediatric and 14% were adult health care providers. The proportion of patients in specialised care decreased continuously within the observed 4-year period to 37% in 20-year-old patients
Alle: 45% zu 30% DMARDs